These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1161476)

  • 1. [Letter: Hyponatremia in cirrhosis and beta blocking agents].
    Sebaoun J; Delzant G; Bentata M; Attali JR; Krivitzky A; Weisselberg C
    Nouv Presse Med; 1975 Apr; 4(16):1212. PubMed ID: 1161476
    [No Abstract]   [Full Text] [Related]  

  • 2. [Which diuretic therapy in be used in patients with liver cirrhosis and hyponatremia, especially with possible kidney failure].
    Stremmel W
    Internist (Berl); 1994 Dec; 35(12):1171. PubMed ID: 7883522
    [No Abstract]   [Full Text] [Related]  

  • 3. [Letter: Ascrtogenicliver cirrhosis. Effect of amiloride on water-electrolytemetabolsim].
    Bianchi Porre G; Lazzaroni M; Petrillo M
    Nouv Presse Med; 1975 Apr; 4(14):1043. PubMed ID: 1093119
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of hyponatremia].
    Seybold D
    Internist (Berl); 1974 Dec; 15(12):594-9. PubMed ID: 4613684
    [No Abstract]   [Full Text] [Related]  

  • 5. [Letter: action of beta-blocking agents in decompensated cirrhosis].
    Sabbah A
    Nouv Presse Med; 1976 Jan; 5(2):91. PubMed ID: 1264644
    [No Abstract]   [Full Text] [Related]  

  • 6. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
    Wong F; Blei AT; Blendis LM; Thuluvath PJ
    Hepatology; 2003 Jan; 37(1):182-91. PubMed ID: 12500203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Water-electrolyte disorders in hepatic cirrhosis with ascites].
    Arroyo V; Rodes J; Sánchez-Tapias JM; Bordas JM; Teres J; Brugera M; Gassull MA
    Rev Clin Esp; 1972 Mar; 124(5):469-76. PubMed ID: 5034135
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyponatremia in cirrhosis with ascites].
    Bronzi G; Orlando D; De Feudis L; Delle Monache G; Scudieri M; Sergiacomo L; Bernardi M; Pesa O
    Minerva Med; 1990 Sep; 81(9):591-6. PubMed ID: 2234478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
    Decaux G
    J Lab Clin Med; 2001 Jul; 138(1):18-21. PubMed ID: 11433224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrolyte depletion in the complications of diuretic therapy in hepatic cirrhosis.
    Shah CP; Shah NV; Acharya PT; Shukla DN
    J Assoc Physicians India; 1968 Sep; 16(9):639-43. PubMed ID: 5711924
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethacrynic acid in patients with salt and water retention-a clinical appraisal.
    Chodakowska J; Filipecki S
    Pol Med J; 1968; 7(4):804-12. PubMed ID: 5727926
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperaldosteronism in acute viral hepatitis, liver cirrhosis and fulminating liver failure].
    Müller G; Spech HJ; Wellhöfer G; Wernze H; Wilkinson SP; Bernardi M
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():436-9. PubMed ID: 1029233
    [No Abstract]   [Full Text] [Related]  

  • 13. [Severe hyponatremia in a case of severe spinal injury: sequential examination of factors affecting water-electrolyte balance].
    Inamura T; Ueno H; Nishiyama T; Nakamura M; Ikezaki K; Inoha S; Nakamizo A; Amano T; Fukui M
    No To Shinkei; 2002 Jan; 54(1):23-7. PubMed ID: 11868347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Water-electrolyte disorders in liver cirrhosis. Accepted ideas and new ideas].
    Lévy VG; Caroli J
    Ann Med Interne (Paris); 1969; 120(6):405-18. PubMed ID: 5807722
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter in response to the recently published review: hyponatremia in cirrhosis and end-stage liver disease--treatment with the vasopressin v2-receptor antagonist tolvaptan.
    Abhyankar A; Robson SC; Tapper EB; Bonder A
    Dig Dis Sci; 2013 Mar; 58(3):889-90. PubMed ID: 23371016
    [No Abstract]   [Full Text] [Related]  

  • 16. [Secondary hyperaldosteronisms].
    Veyrat R; Muller AF; Mach RS
    Presse Med (1893); 1969 Feb; 77(6):189-90. PubMed ID: 4306684
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hyponatremia--clinical aspects and treatment].
    Pupek-Musialik D; Raszeja-Wanic B
    Pol Tyg Lek; 1992 Jul 6-13; 47(27-28):604-7. PubMed ID: 1488338
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent data on the physiopathologic metabolism of aldosterone].
    Jayle MF; Legrand JC; Pasqualini JR
    Expos Annu Biochim Med; 1967; 28():163-96. PubMed ID: 4303008
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum angiotensinase activity in cirrhosis.
    Lubash GD; Hammel EC; Mearles RJ
    Am J Med Sci; 1968 Feb; 255():105-12. PubMed ID: 4295738
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management.
    Ginès P; Guevara M
    Hepatology; 2008 Sep; 48(3):1002-10. PubMed ID: 18671303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.